SCHEMBL6514826

SCHEMBL6514826

COc1ccc(Cc2cc(Cl)nc(Cl)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
LMNA P02545 1/20 0.49
HSP90AB1 P08238 1/20 0.46
LTA4H P09960 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CYP2D6 P10635 1/20 0.45
ATM Q13315 1/20 0.45
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
MAPT P10636 2/20 0.42
ALOX5 P09917 1/20 0.42
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
PDE10A Q9Y233 1/20 0.41
KDM4E B2RXH2 2/20 0.41
CYP17A1 P05093 1/20 0.41
RAB9A P51151 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3404366 0.77 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2HSP90AB1KDM4ERAB9A
SCHEMBL29526036 0.76 ACLY (0.46) ALDH1A1SMN1; SMN2
SCHEMBL22774147 0.76 ACLY (0.46) ALDH1A1SMN1; SMN2
SCHEMBL30366498 0.76 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2LMNAHSP90AB1LTA4H
SCHEMBL7168206 0.75 CLK4 (0.51) SMN1; SMN2LMNAMAPTRAB9A
SCHEMBL28444605 0.73 LTA4H (0.46) ALDH1A1SMN1; SMN2LMNALTA4HNPSR1
Ammonia Solution, Strong SCHEMBL20919857 0.73 LTA4H (0.77) ALDH1A1SMN1; SMN2LMNALTA4HCYP2D6
SCHEMBL3451541 0.72 KDM4E (0.67) ALDH1A1SMN1; SMN2LMNAHSP90AB1MAPK1
SCHEMBL3408439 0.72 ALDH1A1 (0.45) ALDH1A1LMNAHSP90AB1TSHRKDM4E
SCHEMBL29936980 0.72 MAPT (0.46) ALDH1A1SMN1; SMN2LMNALTA4HNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed